M.E. Allison & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.68M Buy
1,449
+22
+2% +$26K 0.94% 27
2026
Q2
$1.71M Hold
1,427
– – 0.99% 25
2026
Q1
$1.31M Sell
1,427
-50
-3% -$50.7K 0.87% 30
2025
Q4
$1.59M Buy
1,477
+10
+0.7% +$9.6K 1.08% 26
2025
Q3
$1.12M Hold
1,467
– – 0.78% 33
2025
Q2
$1.14M Sell
1,467
-20
-1% -$15.5K 0.92% 29
2025
Q1
$1.23M Buy
1,487
+164
+12% +$136K 1.21% 23
2024
Q4
$1.02M Buy
+1,323
New +$1.1M 1.13% 22

Other funds holding LLY

M.E. Allison & Co's LLY Position: Q3 2026 in Review

M.E. Allison & Co increased its Eli Lilly (LLY) stake by 1.5% in Q3 2026, buying an estimated $26K and bringing the position to 1,449 shares worth $1.68M. The position accounts for 0.94% of the portfolio, ranked #27.

M.E. Allison & Co first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.71M in Q2 2026. 1,158 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • M.E. Allison & Co held 1,449 shares of Eli Lilly worth $1.68M as of Q3 2026.
  • M.E. Allison & Co bought 22 Eli Lilly shares in Q3 2026, an estimated $26K.
  • Eli Lilly made up 0.94% of M.E. Allison & Co's portfolio in Q3 2026, its #27 holding.
  • M.E. Allison & Co first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • M.E. Allison & Co's Eli Lilly position peaked at $1.71M in Q2 2026.
  • 1,158 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on M.E. Allison & Co's 13F filing for Q3 2026, filed 9 Oct 2026.